What is it about?
Recently, pretreatment monocyte counts and the lymphocyte/monocyte ratio (LMR) have been proven to be significantly associated with the clinical outcomes of several types of cancer. In this study, we analyzed the prognostic significance of the LMR in stage Ib1–IIa cervical cancer patients who underwent a radical operation.
Featured Image
Why is it important?
To the best of our knowledge, this study is the first to evaluate the influence of the LMR on the RFS and OS in patients with cervical cancer.
Perspectives
we have proven that an elevated LMR is a potential prognostic marker for patients with primary operable cervical cancer. Because this ratio can be easily obtained with a routine blood test, the LMR may be a useful and inexpensive biomarker for predicting the clinical outcome.
Dr Shi-qian Zhang
Qilu Hospital
Read the Original
This page is a summary of: Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1–IIa cervical cancer patients who undergo radical surgery, OncoTargets and Therapy, June 2015, Dove Medical Press,
DOI: 10.2147/ott.s82174.
You can read the full text:
Contributors
The following have contributed to this page
